You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MVA85A

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Safety, Immunogenicity Trial in Entebbe, Oxford (ChAdOx185A, MVA85A, BCG)

Active, not recruiting
  • Safety
  • Immunogenicity
  • ChAdOx185A
  • +2 more
  • Entebbe, Uganda
  • +1 more
May 13, 2021

Tuberculosis Trial in Oxford, Birmingham, London (Aerosol inhaled MVA85A, Intramuscular MVA85A, Intramuscular Saline )

Terminated
Has Results
  • Tuberculosis
  • Aerosol inhaled MVA85A
  • +3 more
  • Oxford, Oxfordshire, United Kingdom
  • +4 more
Aug 14, 2020

Microvascular Coronary Artery Disease Trial in Worldwide (SAR407899, Placebo, Adenosine)

Terminated
Has Results
  • Microvascular Coronary Artery Disease
  • Los Angeles, California
  • +9 more
Mar 15, 2022

Healthy Trial in Cuangugu, Gysenyi, Kigali (Ad26.ZEBOV, MVA-BN-Filo)

Active, not recruiting
  • Healthy
  • Ad26.ZEBOV
  • MVA-BN-Filo
  • Cuangugu, Rwanda
  • +2 more
Jan 17, 2023

Ebola Virus Disease Trial in Freetown (Ad26.ZEBOV, MVA-BN-Filo, MenACWY)

Completed
Has Results
  • Ebola Virus Disease
  • Ad26.ZEBOV
  • +3 more
  • Freetown, Sierra Leone
    (unnamed)
Jun 22, 2022

Covid19 Trial (MVA-SARS-2-S, Placebo)

Withdrawn
  • Covid19
  • MVA-SARS-2-S
  • Placebo
  • (no location specified)
Jul 17, 2023

Lynch Syndrome Trial in Puerto Rico, United States (Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP, MVA

Recruiting
  • Lynch Syndrome
  • Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP
  • +2 more
  • Duarte, California
  • +3 more
Nov 22, 2022

COVID-19 Vaccines Trial in Hannover (MVA-SARS-2-ST)

Recruiting
  • COVID-19 Vaccines
  • MVA-SARS-2-ST
  • Hannover, Germany
    Hannover Medical School ZKS - Early Clinical Trial Unit at CRC H
Sep 6, 2022

Chronic Hepatitis B Trial in Hamburg (HEPLISAV B; TherVacB, TherVacB)

Not yet recruiting
  • Chronic Hepatitis B
  • HEPLISAV B; TherVacB
  • TherVacB
  • Hamburg, Germany
    CTC North
Feb 3, 2023

HIV Trial in Oxford (ChAdOx1.tHIVconsv1 (C1), MVA.tHIVconsv3 (M3), MVA.tHIVconsv4 (M4))

Completed
  • HIV
  • ChAdOx1.tHIVconsv1 (C1)
  • +2 more
  • Oxford, United Kingdom
    Centre for Clinical Vaccinology and Tropical Medicine, Churchill
Aug 10, 2022

Hemorrhagic Fever, Ebola Trial in Worldwide (Ad26.ZEBOV, MVA-BN-Filo, Placebo)

Completed
Has Results
  • Hemorrhagic Fever, Ebola
  • Ad26.ZEBOV
  • +2 more
  • BoboDioulasso, Burkina Faso
  • +6 more
Feb 9, 2022

First Trimester Abortion, Surgical Abortion, Miscarriage With Afibrinogenemia Trial (MateRegen® gel (BioRegen))

Recruiting
  • First Trimester Abortion
  • +2 more
  • MateRegen® gel (BioRegen)
  • Hong Kong, Hong Kong
    The Chinese University of Hong Kong
Oct 30, 2022

Healthy Trial in Oxford (ChAdOx1.HTI and MVA.HTI)

Completed
  • Healthy
  • ChAdOx1.HTI and MVA.HTI
  • Oxford, United Kingdom
    Centre for Clinical Vaccinology and Tropical Medicine, Churchill
Aug 31, 2022

Virus Diseases, Hemorrhagic Fever, Ebola, Infections Trial in Kambia (Ad26.ZEBOV, MVA-BN-Filo)

Recruiting
  • Virus Diseases
  • +10 more
  • Ad26.ZEBOV, MVA-BN-Filo
  • Kambia, Sierra Leone
    EBOVAC Kambia 1 clinic
Oct 11, 2022

HIV-1-infection Trial in Brazil, United States (ChAdOx1.tHIVconsv1, ChAdOx1.HIVconsv62, MVA.tHIVconsv3)

Not yet recruiting
  • HIV-1-infection
  • ChAdOx1.tHIVconsv1
  • +7 more
  • San Diego, California
  • +11 more
Oct 4, 2023

Covid19 Trial in Cologne, Hamburg (MVA-SARS-2-ST)

Active, not recruiting
  • Covid19
  • MVA-SARS-2-ST
  • Cologne, NRW, Germany
  • +1 more
Jun 21, 2022

RSV Infection Trial in London (MVA-mBN294B, Placebo)

Completed
  • RSV Infection
  • MVA-mBN294B
  • Placebo
  • London, United Kingdom
    hVIVO Services Limited
Mar 31, 2022

Antibiotic Side Effect, Probiotics, Diarrhea Trial in Barcelona (Probiotic Lactobacillus acidophilus LA85)

Completed
  • Antibiotic Side Effect
  • +2 more
  • Probiotic Lactobacillus acidophilus LA85
  • Barcelona, Castelldefels, Spain
    Ciurana Clinic
Jul 25, 2023

Myopia, Progressive Trial (IVMED 85, Placebo)

Not yet recruiting
  • Myopia, Progressive
  • IVMED 85
  • Placebo
  • (no location specified)
Mar 7, 2023

Recurrent Wheezing, Wheezing Lower Respiratory Illness Trial (OM-85, Placebo)

Not yet recruiting
  • Recurrent Wheezing
  • Wheezing Lower Respiratory Illness
  • (no location specified)
May 15, 2023

Malaria,Falciparum Trial in Kilifi (R21/Matrix-M, ChAd63/MVA ME-TRAP, intradermal injection (ID) or direct venous injection

Recruiting
  • Malaria,Falciparum
  • R21/Matrix-M
  • +2 more
  • Kilifi, Kenya
    KEMRI/Wellcome Trust Programme, Centre for Geographic Medicine R
Sep 14, 2022

HIV Infection Trial in Badalona (ChAdOx1.HTI at week 0, ConM SOSIP.v7 at weeks 4, 12 and 28, and MVA.HTI at week 22 (CSSMS).,

Recruiting
  • HIV Infection
  • ChAdOx1.HTI at week 0, ConM SOSIP.v7 at weeks 4, 12 and 28, and MVA.HTI at week 22 (CSSMS).
  • Normal saline solution
  • Badalona, Barcelona, Spain
    Germans Trias i Pujol Hospital
Jul 11, 2022

Infertility, Female, IVF, Reproductive Disorder Trial in Nanjing (Mevalproic acid)

Recruiting
  • Infertility, Female
  • +3 more
  • Mevalproic acid
  • Nanjing, Jiangsu, China
    Reproductive Medicine Center, The affiliated Drum Towel Hospital
Mar 28, 2023

HIV Trial (GEO-D03 DNA Vaccine, MVA/HIV62B Vaccine, Placebo for DNA GEO-D03)

Withdrawn
  • HIV Infections
  • GEO-D03 DNA Vaccine
  • +3 more
  • (no location specified)
Nov 4, 2021

Cytomegaloviral Infection, Hematopoietic Cell Transplant Recipient Trial in Duarte (Laboratory Biomarker Analysis, Multi-peptide

Recruiting
  • Cytomegaloviral Infection
  • Hematopoietic Cell Transplant Recipient
  • Laboratory Biomarker Analysis
  • Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
  • Duarte, California
    City of Hope Medical Center
Jun 14, 2022